Tagra Biotechnologies Ltd.
Tagra Biotechnologies Ltd. is an Israel-based specialty ingredients company that develops and manufactures microencapsulated actives, pigments, and UV filters for B2B cosmetics manufacturers worldwide. Founded in 1998, it sells proprietary breakable, water-soluble, and unbreakable capsule technologies through a global distributor network spanning 30+ countries.
- Company typePrivate
- Founded1998
- HeadquartersNetanya, Israel
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
What Tagra Biotechnologies Ltd. does
Tagra Biotechnologies Ltd. is an Israel-based (Netanya) specialty ingredients company founded in 1998 that develops and manufactures microencapsulated actives, pigments, essential oils, and UV filters for the global cosmetics industry. Its platform rests on three proprietary microcapsule architectures: breakable capsules built on Release on Demand (RND™) technology that rupture upon application to release actives (CelluCaps™, DeeperCaps™, Cameleon CelluCaps™, CelluOils™); water-soluble capsules (WS SA50™, WS Biotin™) that use polymer complexation to convert poorly soluble compounds into water-dispersible powders; and unbreakable cellulose-based polymer shell capsules (SunCaps™) that isolate UV filters to prevent skin penetration. The R&D engine, staffed by PhD experts in microparticulate delivery systems, has produced over 14 patents and 27+ years of accumulated know-how, with portfolio extensions addressing inclusive beauty (dark-skin pigments), sun care safety, and alcohol-free formulation challenges.
Tagra operates as a B2B ingredient supplier and does not sell finished consumer products. It monetizes through one-time sales of encapsulated ingredients to cosmetics manufacturers and through professional services in the form of custom formulation and R&D support that helps customers integrate Tagra's ingredients into proprietary formulations. Pricing is not publicly disclosed and is quote-based, typically tied to volume and product specifications under multi-year contracts with customers. The go-to-market motion is overwhelmingly indirect: Tagra reaches 30+ countries through a network of more than 20 authorized regional distributors, including major specialty chemical distributors such as Azelis (multiple regions), DKSH (Asia Pacific and Italy), Caldic (UK), IMCD (Israel), Amerilure (US Northeast), Grupo Carcen (Central America), Focus Quimica (Brazil), Andicor (Canada), and Xitrix (US Southeast). Tagra supplements this channel with direct website engagement (sample and formula request engine) and a thought-leadership podcast (Demystifying Cosmetics) targeting formulators, chemists, and product developers. Its operating geographies span the Americas, Europe, the Middle East, Africa, and Asia Pacific, with the company claiming global regulatory compliance including China, backed by ISO 9001:2015, ISO 14001:2015, ISO 22716:2007 GMP, and EcoVadis Gold certifications. The company is privately held with 101-250 employees, led by CEO and founder Ron Folman, CFO Ronen Roshkin, and Chief Scientist Shaher Duchi, and has not disclosed any external funding rounds or institutional investment.
Tagra Biotechnologies Ltd. firmographics
Firmographics- Name
- Tagra Biotechnologies Ltd.
- Legal name
- TAGRA Biotechnologies Ltd.
- Website
- https://tagra.com
- Company type
- Private
- Founded year
- 1998
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- Tagra Biotechnologies Ltd. is an Israel-based specialty ingredients company that develops and manufactures microencapsulated actives, pigments, and UV filters for B2B cosmetics manufacturers worldwide. Founded in 1998, it sells proprietary breakable, water-soluble, and unbreakable capsule technologies through a global distributor network spanning 30+ countries.
- Ownership category
- akta.pro rank
Tagra Biotechnologies Ltd. industry classification
Industry- Product category
- Cosmetic Ingredients
- NAICS
- Soap and Cleaning Compound Manufacturing (32561)
- SIC
- Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation) (AFAJACAL)
Keywords
Where Tagra Biotechnologies Ltd. is headquartered
LocationHeadquarters
- HQ city
- Netanya
- HQ country
- Israel
- HQ region
- Middle East
Offices1 record
Markets served
Tagra Biotechnologies Ltd. business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Supply Chain, Operations, Marketing or Sales, Infrastructure
Revenue model
- Microencapsulated Actives and Ingredients B2B Sales: Tagra sells microencapsulated active ingredients, pigments, essential oils, and UV filters directly to cosmetics manufacturers. Products are sold as functional ingredients for incorporation into finished cosmetic formulations rather than finished consumer products.
- Custom Formulation and Development Services: Tagra provides R&D support and formulation assistance to customers, helping create customized proprietary technology, color, skin care complexes and first-to-market innovations.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | B2B ingredient pricing |
Go-to-market motion2 records
Distribution channels1 record
Marketing channels4 records
Tagra Biotechnologies Ltd. product offering
Product offeringCore offering
Tagra Biotechnologies Ltd. manufactures and supplies microencapsulated active ingredients, pigments, essential oils, and UV filters for the global cosmetics industry. The company uses its proprietary Release on Demand (RND™) technology and cellulose-based polymer shells to protect active ingredients from environmental degradation, enable controlled release upon application, and convert poorly water-soluble compounds into water-soluble powders. Products are sold as functional ingredients that cosmetics manufacturers incorporate into their own finished formulations.
Product overview
Tagra Biotechnologies Ltd. is a leading producer of innovative microencapsulated actives and pigments for the cosmetic industry. The company's portfolio centers on its core microencapsulation technology platform with three main product categories: Breakable Microcapsules (CelluCaps™, DeeperCaps™, Cameleon CelluCaps™, CelluOils™) that release on demand upon application; Water-Soluble Microcapsules (WS SA50™, WS Biotin™) that enhance solubility of poorly water-soluble compounds; and Unbreakable Microcapsules (SunCaps™) for encapsulated UV filters. All products utilize either the proprietary Release on Demand (RND™) technology for breakable capsules or cellulose-based polymer shells for unbreakable formulations, enabling customers to create cutting-edge cosmetic formulations with improved stability, controlled release, and enhanced performance.
Differentiator
Problem solved
Functional benefit
Brands
- CelluCaps™: Breakable microcapsules for encapsulation of active ingredients using Release on Demand (RND) technology.
- SunCaps™
- WS SA50™
- WS Biotin™
- Cameleon CelluCaps™
- DeeperCaps™
- CelluOils™
- Demystifying Cosmetics
Products and services
- CelluCaps™ Breakable microcapsules that encapsulate cosmetic active ingredients using Release on Demand (RND™) technology, preserving potency and efficacy until application. The cellulose-based shells protect ingredients from light, temperature, pH, and oxidation during storage and manufacturing, then release contents upon mechanical pressure (rubbing) during use. Targeted at cosmetics manufacturers formulating skincare, color cosmetics, hair care, and scalp care products.
- DeeperCaps™ Microencapsulated pigments specifically designed for dark skin cosmetics, ensuring smooth formulation without unintended mixing and providing natural tone matching without white-cast effect. The encapsulated pigments contain Shea Butter for moisturization. Targeted at color cosmetics manufacturers developing inclusive beauty products for diverse skin tones.
- Cameleon CelluCaps™ Green, cellulose-based microencapsulated pigments with a Natural Origin Index of 0.83–0.95, considered 'Naturally Derived' per ISO 16128. The color-changing microcapsules break upon application to deliver dramatic and consistent color transformation. Targeted at color cosmetics formulators seeking natural pigments and innovative visual effects.
- CelluOils™ Encapsulated essential oils that protect natural oils for fresh, long-lasting release upon application. Converts liquid oils into powder form for dispersion across all formulation phases. Available variants include Eucalyptus, Tea Tree Oil, Evening Primrose, Geranium, Lavender, and Menthol. Targeted at cosmetics manufacturers formulating skincare and personal care products with natural essential oils.
- WS SA50™ Water-soluble salicylic acid microcapsule that increases solubility from 0.2% to 5%, enabling alcohol-free formulations for skincare and haircare. Maintains acidic pH without need for organic solvents, prevents crystallization and discoloration, and is loaded with 50% Salicylic Acid. Targeted at skincare and haircare formulators building anti-acne, exfoliating, and scalp care products.
- WS Biotin™
- SunCaps™ Unbreakable, transparent encapsulated UV filters using cellulose-based polymer shells. Prevents skin penetration and degradation of UV filters while improving UV protection profile and eliminating the need for UV filter solubilizers, allowing lighter, smoother, non-greasy sunscreen formulations. Available variants include AvoCap™ 2, OmcCap™, OctiCap™, OctoCap™, HomeCap™, Cellu ZinoCap™, and Cellu TitanCap™. Targeted at sun care and daily skincare formulators.
Quantifiable outcome
- WS SA50™ increases Salicylic Acid water solubility from 0.2% to 5%
- +2 more outcomes
Companies that use Tagra Biotechnologies Ltd.
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
Tagra Biotechnologies Ltd. technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Tagra Biotechnologies Ltd. partnerships and signals
Strategic signalPartnerships
22 partnerships are on record, tiered regional.
- AmerilureregionalAmerilure is Tagra's authorized distributor in the Northeastern United States (New Jersey). Contact: Diana D'Ecclesiis. Provides local sales and distribution of Tagra microencapsulation products.
- Azelis USAregionalAzelis USA is Tagra's authorized distributor for Midwest and West Coast USA (Santa Fe Springs, California). Contact: Chris Aiuto.
- Azelis ChinaregionalAzelis China is Tagra's authorized distributor in Shanghai, China. Contact: Anthony Li. Azelis China has developed multiple formulations with Tagra products including Whitening Revitalizing Cream and Unicorn Lip Stick.
- Azelis EMEA DACHregionalAzelis Deutschland Kosmetik GmbH is Tagra's authorized distributor in Germany (Dusseldorf). Contact: Markus Schünke. Developed formulations including Moisturizing CC Cream SPF30.
- DKSHregionalDKSH (DKSH Thailand, DKSH Taiwan, DKSH Philippines, DKSH Vietnam, DKSH Japan, DKSH Korea) is Tagra's authorized distributor across multiple Asia Pacific markets. Provides regional coverage and local support.
- IMCD IsraelregionalIMCD Israel is Tagra's authorized distributor in Israel. Located in Netanya. Contact: Tova Yehuda.
- CaldicregionalCaldic is Tagra's authorized distributor in the United Kingdom (Derbyshire, England). Contact: Ed Britton.
- Azelis NordicsregionalAzelis Nordics is Tagra's authorized distributor covering Nordic countries (Malmö, Sweden). Contact: Pernille Moberg.
- Azelis BeneluxregionalAzelis Benelux is Tagra's authorized distributor in Belgium (Heusden). Contact: Evelien Deschuyter.
- Comercial Quimica MassoregionalComercial Quimica Masso is Tagra's authorized distributor covering Hungary (Budapest), Poland (Warszawa), and Spain (Barcelona).
- Gravity ChemicalsregionalGravity Chemicals is Tagra's authorized distributor covering India and Sri Lanka (Karnataka, India). Contact: M P Reji.
- Azelis AustraliaregionalAzelis Australia is Tagra's authorized distributor in Australia (New South Wales). Contact: Kim Newham.
- Azelis New ZealandregionalAzelis New Zealand is Tagra's authorized distributor in New Zealand (Auckland). Contact: Tulaki Tuinukuafe.
- Azelis RomaniaregionalAzelis Romania is Tagra's authorized distributor in Romania (Bucharest). Contact: Gabriela Mirica.
- DKSH ItaliaregionalDKSH Italia S.r.l. is Tagra's authorized distributor in Italy (Milano). Contact: Alberto Montano.
- Azelis GreeceregionalAzelis Greece S.A. is Tagra's authorized distributor in Greece (Athens). Contact: George Niakos.
- Azelis FranceregionalAzelis France is Tagra's authorized distributor in France (Paris). Contact: Anais Mora.
- Andicor Speciality ChemicalsregionalAndicor Speciality Chemicals is Tagra's authorized distributor in Canada (Ontario). Contact: Andrea Boylan.
- Grupo CarcenregionalGrupo Carcen is Tagra's authorized distributor in Central America. Contact: Sonia Montenegro.
- Focus QuimicaregionalFocus Quimica is Tagra's authorized distributor in Brazil (São Paulo). Contact: Amanda Omodei.
- XitrixregionalXitrix is Tagra's authorized distributor in USA Southeast (North Carolina). Contact: Michelle Linscott.
- Cosmetic-IngredientsregionalCosmetic-Ingredients is Tagra's authorized distributor in South Africa (Centurion). Contact: Shani Vermeulen.
Scale indicators3 records
Recent moves6 records
Expansion highlights6 records
Tagra Biotechnologies Ltd. competitors and assessment
Company assessmentBroad incumbents
- Givaudan Active Beauty: Givaudan's Active Beauty division supplies cosmetic actives, encapsulated ingredients, and sensory solutions to global cosmetics brands. Comparable B2B specialty ingredient supplier with significantly greater scale and direct customer relationships.
- Evonik Personal Care: Evonik's Personal Care business offers specialty ingredients including encapsulated actives, conditioning agents, and UV filter solutions to global cosmetics and personal care brands. Competes with Tagra in the same formulation ingredient categories and customer segments.
- Lubrizol Life Science (Berkshire Hathaway): Lubrizol's Life Science division offers personal care and cosmetic specialty ingredients including polymers, actives, and encapsulation technologies. Overlaps with Tagra in formulation ingredient supply to global cosmetics manufacturers.
- Sensient Technologies: Sensient Technologies provides specialty cosmetic colorants, pigments, and personal care ingredients globally. Directly comparable to Tagra's color cosmetic segment (DeeperCaps, Cameleon CelluCaps) and competes in encapsulated pigment technologies for cosmetics manufacturers.
- Croda International: Croda is a global specialty chemical company providing cosmetic actives, encapsulated ingredients, and personal care formulation ingredients. Overlaps with Tagra's customer base of cosmetics manufacturers and competes in skincare, sun care, and color cosmetic ingredient categories.
- Seppic (Air Liquide Healthcare): Seppic, an Air Liquide subsidiary, provides specialty ingredients and formulation aids for cosmetics including emulsifiers, active ingredients, and encapsulation systems. Comparable as a B2B specialty cosmetic ingredient supplier serving formulators globally.
- DSM-Firmenich: DSM-Firmenich provides beauty and personal care ingredients including encapsulated actives, vitamins, UV filters, and pigments. Serves the same global cosmetics manufacturer customer base as Tagra with extensive direct sales infrastructure.
- Lonza Personal Care & Nutrition: Lonza provides specialty ingredients including encapsulated actives and cosmetic formulation ingredients for personal care applications. Comparable as a B2B supplier to global cosmetics manufacturers with strong GMP credentials and broader portfolio.
- BASF Personal Care: BASF's Personal Care division offers a comprehensive portfolio of cosmetic active ingredients including encapsulated actives, UV filters, and pigments, serving the same global cosmetics manufacturer customer base as Tagra with vastly greater scale and direct sales coverage.
Direct peers
- Encapsys (Milliken): Encapsys, a Milliken subsidiary, is a microencapsulation specialist serving personal care, household, and industrial markets with controlled-release encapsulation technologies. Direct peer to Tagra in core microencapsulation capability and target customers (cosmetics and personal care manufacturers).
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Tagra Biotechnologies Ltd. social profiles
Digital presenceTagra Biotechnologies Ltd. compliance and trust
Trust signalCompliance7 records
Tagra Biotechnologies Ltd. financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tagra Biotechnologies Ltd. leadership team
Management profileNumber of profiles
Profiles3 records
Tagra Biotechnologies Ltd. funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tagra Biotechnologies Ltd. M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tagra Biotechnologies Ltd.
What does Tagra Biotechnologies Ltd. do?
Tagra Biotechnologies Ltd. manufactures and supplies microencapsulated active ingredients, pigments, essential oils, and UV filters for the global cosmetics industry. The company uses its proprietary Release on Demand (RND™) technology and cellulose-based polymer shells to protect active ingredients from environmental degradation, enable controlled release upon application, and convert poorly water-soluble compounds into water-soluble powders. Products are sold as functional ingredients that cosmetics manufacturers incorporate into their own finished formulations.
Is Tagra Biotechnologies Ltd. a public or private company?
Tagra Biotechnologies Ltd. is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Tagra Biotechnologies Ltd. founded?
Tagra Biotechnologies Ltd. was founded in 1998. It employs 101 to 250 people.
Where is Tagra Biotechnologies Ltd. based?
Tagra Biotechnologies Ltd. is headquartered in Netanya, Israel, in the Middle East region.
How does Tagra Biotechnologies Ltd. make money?
Two revenue lines are on record. Microencapsulated Actives and Ingredients B2B Sales are the primary driver. The others are custom Formulation and Development Services.
Who are Tagra Biotechnologies Ltd.'s main competitors?
Broad incumbents on record are Givaudan Active Beauty, Evonik Personal Care, Lubrizol Life Science (Berkshire Hathaway), Sensient Technologies, Croda International, Seppic (Air Liquide Healthcare), DSM-Firmenich, Lonza Personal Care & Nutrition and BASF Personal Care. Encapsys (Milliken) is listed as a direct peer.
Does Tagra Biotechnologies Ltd. have an API?
No public API is recorded for Tagra Biotechnologies Ltd..
What industry is Tagra Biotechnologies Ltd. in?
Tagra Biotechnologies Ltd.'s product category is Cosmetic Ingredients. Its primary akta.pro industry code is AFAJACAL, Encapsulation & Emulsified Delivery Systems (Spray-dried emulsions, Lipid microencapsulation). Its NAICS code is 32561 and its SIC code is 2844.